Preclinical characterization of VX-984, a selective DNA-dependent protein kinase (DNA-PK) inhibitor in combination with doxorubicin in breast and ovarian cancers

被引：5
|
作者：
Boucher, D. [1 ]
Newsome, D. [1 ]
Takemoto, D. [1 ]
Hillier, S. [1 ]
Wang, Y. [1 ]
Arimoto, R. [1 ]
Maxwell, J. [1 ]
Charifson, P. [1 ]
Fields, S. Z. [1 ]
Tanner, K. [1 ]
Penney, M. S. [1 ]
机构：
[1] Vertex Pharmaceut Inc, Boston, MA USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P5-06-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-06-05
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma
    Collins, Victor J.
    Ludwig, Katelyn R.
    Nelson, Ariana E.
    Rajan, Soumya Sundara
    Yeung, Choh
    Vulikh, Ksenia
    Isanogle, Kristine A.
    Mendoza, Arnulfo
    Difilippantonio, Simone
    Karim, Baktiar O.
    Caplen, Natasha J.
    Heske, Christine M.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (08) : 1109 - 1123
  • [22] DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine
    Meador, Jarah A.
    Su, Yanrong
    Ravanat, Jean-Luc
    Balajee, Adayabalam S.
    CARCINOGENESIS, 2010, 31 (02) : 184 - 191
  • [23] ACTIVITY OF THE DNA-DEPENDENT PROTEIN-KINASE (DNA-PK) MAY REQUIRE 2 DISTINCT PROTEINS
    SUN, SS
    MALIK, NP
    LUGOAYALA, E
    VANCUROVA, I
    CARTER, TH
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 304 - 304
  • [24] The DNA-dependent protein kinase (DNA-PK) More than just a case of making ends meet?
    Hill, Richard
    Lee, Patrick W. K.
    CELL CYCLE, 2010, 9 (17) : 3460 - 3469
  • [25] The activity of the DNA-dependent protein kinase (DNA-PK) complex is determinant in the cellular response to nitrogen mustards
    Muller, C
    Calsou, P
    Salles, B
    BIOCHIMIE, 2000, 82 (01) : 25 - 28
  • [26] DNA-Dependent Protein Kinase (DNA-PK)-Dependent Cisplatin-Induced Loss of Nucleolar Facilitator of Chromatin Transcription (FACT) and Regulation of Cisplatin Sensitivity by DNA-PK and FACT
    Dejmek, Janna
    Iglehart, J. Dirk
    Lazaro, Jean-Bernard
    MOLECULAR CANCER RESEARCH, 2009, 7 (04) : 581 - 591
  • [27] Activation of DNA-dependent protein kinase (DNA-PK) may play a role in apoptosis of human neuroblastoma cells
    Chakravarthy, BR
    Walker, T
    Rasquinha, I
    Hill, IE
    MacManus, JP
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 : S51 - S51
  • [28] DNA-dependent protein kinase (DNA-PK) phosphorylates and activates TonEBP/NFAT5 in response to hypertonicity
    Lee, SD
    Colla, E
    Park, WK
    Chen, DJ
    Kwon, HM
    FASEB JOURNAL, 2003, 17 (04): : A482 - A482
  • [29] DEVELOPMENT OF DNA-DEPENDENT PROTEIN-KINASE (DNA-PK) ASSAY SYSTEM USING HUMAN AUTOANTIBODIES AGAINST THE 350-KDA CATALYTIC SUBUNIT OF DNA-PK
    SUWA, A
    MIMORI, T
    WATANABE, F
    TERAOKA, H
    HIRAKATA, M
    INADA, S
    HARDIN, JA
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1001 - 1001
  • [30] A multicenter phase I trial of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814 in patients with solid tumors.
    van Bussel, Mark
    Mau-Soerensen, Morten
    Damstrup, Lars
    Nielsen, Dorte
    Verheul, Henk M. W.
    Aftimos, Philippe Georges
    De Jonge, Maja J.
    Berghoff, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345